Amgen Hit With US Eylea Suit Ahead Of Looming Biosimilar Date

California-Based Firm Submitted Aflibercept Application Late Last Year

• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products